Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CNR2 antibody (3rd Intracellular Loop)

The Rabbit Polyclonal anti-CNR2 antibody (ABIN7043025) specifically detects CNR2 in WB and IHC. The antibody is reactive with Rat samples.
Catalog No. ABIN7043025
$854.77
Plus shipping costs $50.00
Shipping to: United States
Delivery in 11 to 14 Business Days

Quick Overview for CNR2 antibody (3rd Intracellular Loop) (ABIN7043025)

Target

See all CNR2 Antibodies
CNR2 (Cannabinoid Receptor 2 (CNR2))

Reactivity

  • 60
  • 28
  • 24
  • 2
  • 1
  • 1
Rat

Host

  • 60
  • 5
  • 1
Rabbit

Clonality

  • 61
  • 5
Polyclonal

Conjugate

  • 36
  • 6
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CNR2 antibody is un-conjugated

Application

  • 56
  • 32
  • 30
  • 23
  • 13
  • 13
  • 10
  • 9
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Binding Specificity

    • 16
    • 12
    • 10
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    3rd Intracellular Loop, AA 228-242

    Purpose

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2

    Cross-Reactivity

    Mouse, Rat

    Predicted Reactivity

    Mouse - identical Human - 14 out of 15 amino acid residues identical

    Characteristics

    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogen

    (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotype

    IgG
  • Application Notes

    WB: 1:200

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: 1:100-1:400

    IP: The optimal concentration should be determined by the user

    Comment

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    CNR2 (Cannabinoid Receptor 2 (CNR2))

    Alternative Name

    CNR2

    Background

    Synonyms: CB2, CNR2

    Description: Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    Gene ID

    57302

    NCBI Accession

    NM_001841

    UniProt

    Q9QZN9
You are here:
Chat with us!